Effect of telmisartan and enalapril on ventricular remodeling and kidney prognosis of patients with coronary artery disease complicated with diabetic nephropathy.

In conclusion, the regular telmisartan treatment for patients with coronary artery disease complicated with diabetic nephropathy is better than enalapril on ventricular remodeling and kidney prognosis. PMID: 28123481 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28123481?dopt=Abstract

Source: Experimental and Therapeutic Medicine - January 27, 2017 Category: Journals (General) Tags: Exp Ther Med Source Type: research